Teaching, talks, and education on the the economics of psychedelics 

TALKS

Presentations

Who is going to pay for psychedelic therapies?
UC Berkeley Center for Law and Technology
🗓️ January 14, 2026
📍 UC Berkeley via Zoom

Agenda for the Economic Evaluation of Psychedelic Therapies
UAB - Psychedelic Studies Forum 
🗓️ Nov. 17, 2022
📍 Birmingham AL - via zoom

Psychedelic – Assisted Therapies for Psychiatric and Behavioral Disorders: Overview of Efficacy and Economics
Sri Ramachandra Institute of Higher Education and Research, Department of Psychiatry
🗓️ July 24, 2024
📍 Chennai, India - via Zoom

Health Economics & Psychedelics with the BCSP, Elliot Marseille, Jennifer Mitchell.
UC Berkeley Center for the Science of Psychedelics 
🗓️ November 9, 2023
📍 UC Berkeley’s Li Ka Shing Center, Room 125.

Agenda for the Economic Evaluation of Psychedelic Therapies
Horizons: Perspectives on Psychedelics
🗓️ Oct. 13, 2022
📍 Birmingham AL - via zoom

Assessing readiness for implementation of a novel psychiatric pharmacotherapy, psychedelic-assisted psychotherapy, in Low- and Middle- Income Countries
Virginia Commonwealth University School of Medicine Symposium
🗓️ September 9, 2023
📍 Richmond, VA

Opinion Pieces

  • San Francisco should help test ibogaine for potential fentanyl treatment.

    Marseille, E.
    SF Chronicle Op-Ed.
    January 22, 2026.

    Link

  • The microdosing mirage: What science says about the Bay Area’s latest wellness trend

    Marseille, E., Raison, C.
    SF Chronicle Op-Ed.
    August 31, 2025.

  • Where the Trump administration and Bay Area progressives agree: Psychedelics

    Marseille, E., Bertozzi, S.
    SF Chronicle Op-Ed.
    July 21, 2025.

  • Crunching the numbers on psychedelic therapies: cost coverage and access.

    Marseille, E.
    MAPS Bulletin 2025: Volume 35
    October 2025.

    Link

Other Invited Presentations

  • Elevating Well-Being as a Primary Outcome

    UW, Madison; Symposium on Psychedelics
    🗓️ November 14, 2025
    📍 Madison, WI

  • Frontiers of the Economics of Psychedelics.

    Usona Institute
    🗓️ November 13, 2025
    📍 Madison, WI

  • Economics of MDMA‑Assisted Therapy for PTSD in Ukraine

    Ukrainian Psychedelic Research Association and the Psychedelic Access and Research European Alliance
    🗓️ September 29, 2025
    📍 Lyviv, Ukraine via Zoom

  • Panel on integrating state legal psychedelic models

    MAPS, Psychedelic Science 2025
    🗓️ June 16-20, 2025
    📍 Denver, CO

  • The Potential Economic and Public Health Impact of MDMA-Assisted Therapy for PTSD in Ukraine

    5th Annual Psychedelic Therapeutics and Drug Development Conference
    🗓️ May 19-20, 2025
    📍 San Diego, CA

  • Psychedelic safety from an economic perspective

    Psychedelic Safety Summit
    🗓️ March 19-21, 2025
    📍 Berkeley, CA

  • Making the case: Why economics matters for psychedelic therapies

    Federal Summit on Psychedelic Medicine Policy
    🗓️ May 8, 2025
    📍 Washington, DC

  • Economic Analyses at the Intersection of Addiction and Psychedelic Therapies

    University of Washington
    🗓️ March 12, 2025
    📍 Brower Center, Berkeley, CA

  • Current issues on the economics of psychedelic therapies

    Penn Psychedelics Collaborative
    🗓️ October 3- 6, 2024
    📍 Philadelphia, PA

  • Panels on Market access and health economics; Presentation on the Costs and benefits of MDMA-Assisted Therapy for PTSD in Ukraine

    Interdisciplinary Conference on Psychedelic Research - ICPR
    🗓️ June 6-8, 2024
    📍Haarlem, The Netherlands

  • Estimating the costs and benefits of MDMA-Assisted Therapy for PTSD in Ukraine

    Czech Psychedelic Research Foundation (PSYRES)
    🗓️ May 29, 2024
    📍 Prague, Czeck Republic

  • Overview of the economics of the delivery of psychedelic therapies

    Discovery Sessions
    🗓️ April 18-19, 2024
    📍 San Francisco, CA

  • Recent findings in the economics of psychedelic therapies

    Australian Reading Group on Psychedelic Science
    🗓️ April 3, 2024
    📍 Virtual/Remote

  • Economic and Access Effects of group MDMA-Assisted Therapy for PTSD Scenario Analyses Including Exploratory Results for Veterans

    VA Office of of Research and Development + VA Office of Mental Health and Suicide Prevention
    🗓️ September 8, 2023
    📍 Virtual

  • Economics of group psychedelic therapy - Effects on cost and clinician supply (E. Marseille) 2. Status of cost-effectiveness of psilocybin for major depression (A. Avancena)

    Psychedelic Therapeutics & Drug Development Conference
    🗓️ May 15-16, 2023.
    📍 San Francisco, CA

  • Panel: "Achieving Reimbursement" (E.Marseille) & Poster: Cost-effectiveness of psilocybin for major depression (A. Avancena)

    MAPS Psychedelic Science 2023
    🗓️ June 19 -23, 2023
    📍 Boulder, CO

  • Current status of the economic evaluation of psychedelic therapies

    SAMHSA - Federal Task Force planning meeting
    🗓️ Jan. 18, 2023
    📍 Washington DC - via zoom

  • Agenda for the Economic Evaluation of Psychedelic Therapies

    Stockton University
    🗓️ Nov. 12, 2022
    📍 Atlanta - via zoom

  • Assessing the Value of Psychedelic Therapies to Payers and Society

    Insight 2021
    🗓️ Sept. 11, 2021
    📍 Berlin

  • Is MDMA-assisted therapy for severe, chronic PTSD, cost-effective?

    American Society for Clinical Psychopharmacology
    🗓️ June 1, 2021
    📍 Virtual - via zoom